Cargando…
Pleiotropic effects of NOACs with focus on edoxaban: scientific findings and potential clinical implications
Non-vitamin K antagonist oral anticoagulants (NOACs) are well-established as inhibitors of factor Xa (FXa) and thrombin in the treatment and prevention of thrombosis. However, there is growing evidence that beneficial outcomes might be based on additional pleiotropic effects beyond anticoagulation....
Autores principales: | Goette, Andreas, Mollenhauer, Martin, Rudolph, Volker, Lamparter, Mathias, Meier, Martin, Böhm, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Medizin
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229706/ https://www.ncbi.nlm.nih.gov/pubmed/37140824 http://dx.doi.org/10.1007/s00399-023-00944-5 |
Ejemplares similares
-
Periinterventional Management of Edoxaban in Major Procedures: Results from the DRESDEN NOAC REGISTRY
por: Köhler, Christina, et al.
Publicado: (2023) -
Lack of reversibility for NOACs
por: Al-Kindi, Sadeer
Publicado: (2014) -
TAVR: nemesis of NOACs?
por: Polzin, Amin, et al.
Publicado: (2022) -
Response to ‘Lack of reversibility for NOACs’
por: Kaba, Riyaz A, et al.
Publicado: (2014) -
Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design
por: Baldus, Stephan, et al.
Publicado: (2023)